Walter Hanel

Title: Walter Hanel: Innovator in IL-17 Receptor Research

Introduction

Walter Hanel is a notable inventor based in Stony Brook, NY (US). He has made significant contributions to the field of immunology, particularly through his innovative work on the IL-17 receptor. His research has implications for treating inflammatory and autoimmune diseases.

Latest Patents

Walter Hanel holds a patent for the invention titled "Pre-ligand assembly domain of the IL-17 receptor." This invention provides isolated Pre-Ligand Assembly Domain (PLAD) polypeptides that comprise an amino acid sequence of a domain of an IL-17 Receptor (IL-17R) family member. The PLAD polypeptide inhibits the multimerization of a receptor complex comprising an IL-17R family member. Additionally, the patent includes isolated PLAD-binding polypeptides, such as antibodies and avimers, which specifically bind to the described PLAD polypeptide. The invention also outlines methods for treating inflammatory or autoimmune diseases and inhibiting IL-17-mediated signal transduction.

Career Highlights

Walter Hanel has worked with prominent organizations, including Amgen Inc. and the State University of New York. His career has been marked by a commitment to advancing scientific understanding and developing therapeutic solutions.

Collaborations

Walter has collaborated with notable colleagues, including Fang Shen and Michael Wittekind. Their combined expertise has contributed to the success of his research endeavors.

Conclusion

Walter Hanel's innovative work on the IL-17 receptor has the potential to significantly impact the treatment of inflammatory and autoimmune diseases. His contributions to science exemplify the importance of research and innovation in addressing complex health challenges.